Sorrento Therapeutics Inc (SRNE): MEXICO! Easy Breezy there's a fungus...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	2336
Boards Moderated	0
Alias Born	04/20/2006

1776club

Re: None

Wednesday, 08/11/2021 4:57:30 PM

Wednesday, August 11, 2021 4:57:30 PM

MEXICO! Easy Breezy there's a fungus among us.
How to you build a facility to make Vaccines?
Exclusive rights to Dyadic International's (DYAI) C1-cell protein production platform for the development of vaccines and therapeutics for coronaviruses, including Dyadic's COVID-19 vaccine candidate DYAI-100.
The license will grant the company exclusive rights in North America and South America, Europe and certain countries to develop and commercialize vaccines, therapeutics and diagnostics for coronaviruses produced using the C1 technology, according to a statement.
A significant biopharmaceutical gene expression platform based on the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1.
Worth the read...
https://irdirect.net/prviewer/release_only/id/4651797

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM